Business

Tandem Diabetes Care to Announce Third Quarter 2020 Financial Results on November 5, 2020

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its

articleTandem Diabetes Care, Inc.October 8, 20204/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-to-announce-third-quarter-2020-financial-results-on-november-5
Tandem Diabetes Care to Announce Third Quarter 2020 Financial Results on November 5, 2020

About this update from Tandem Diabetes Care, Inc.

[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nTandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2020 results after the financial markets close on Thursday, November 5, 2020. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2020 financial and operating results.\n\nConference Call/Webcast Details:\nDate: November 5, 2020\nTime: 4:30 pm Eastern Time (1:30 pm Pacific Time)\nToll Free Dial-In Number: (855) 427-4396\nInternational Dial-In Number: (484) 756-4261\nConference ID: 8072078\nWebcast Link: https://edge.media-server.com/mmc/p/mp7mdi2q\n\nAn archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.\n\nAbout Tandem Diabetes Care, Inc.\n\nTandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California.\n\nFollow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.\nFollow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.\nFollow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.\n\nTandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20201008005093/en/\n\nMedia Contact:\nSteve Sabicer\n714-907-6264\[email protected]\n\nInvestor Contact:\nSusan Morrison\n858-366-6900 x7005\[email protected]\n\nSource: Tandem Diabetes Care, Inc.","length":5611,"tagName":"div"}]

More updates from Tandem Diabetes Care, Inc.